OTLK Historical Earnings image   This OTLK historical earnings page last updated 7/15/2024
OTLK Historical Revenue
PeriodHistorical Earnings DateGAAP
Q2 20245/15/2024NA
Q1 20242/14/2024NA
Q4 202312/22/2023NA
Q3 20238/14/2023NA
Q2 20235/15/2023NA
Q1 20232/14/2023NA
Q4 202212/29/2022NA
Q3 20228/10/2022NA
Q2 20225/13/2022NA
Q1 20222/14/2022NA
Q4 202112/22/2021NA
Q3 20218/13/2021NA
Q2 20215/14/2021NA
Q1 20212/16/2021NA
Q4 202012/23/2020NA
Q3 20208/14/2020NA
Q2 20205/15/2020NA
Q1 20202/14/2020NA
Q4 201912/19/20195.85M
Q3 20198/14/20190.00B
Q2 20195/15/20190.00B
OTLK Historical Earnings EPS
PeriodHistorical Earnings DateAdj. EPS
Q2 20245/15/2024-1.550
Q1 20242/14/2024-0.800
Q4 202312/22/2023-1.000
Q3 20238/14/2023-1.600
Q2 20235/15/2023-0.600
Q1 20232/14/2023-1.600
Q4 202212/29/2022-1.200
Q3 20228/10/2022-1.600
Q2 20225/13/2022-1.800
Q1 20222/14/2022-1.400
Q4 202112/22/2021-1.600
Q3 20218/13/2021-1.400
Q2 20215/14/2021-1.800
Q1 20212/16/2021-2.400
Q4 202012/23/2020-0.600
Q3 20208/14/2020-2.200
Q2 20205/15/2020-2.600
Q1 20202/14/2020-12.400
Q4 201912/19/20191.000
Q3 20198/14/2019-4.800
Q2 20195/15/2019-11.600
Quotes delayed 20 minutes

Email EnvelopeFree OTLK Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Outlook Therapeutics (OTLK) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

OTRK Historical Earnings
OVID Historical Earnings
OYST Historical Earnings
PACB Historical Earnings
PACS Historical Earnings
PAHC Historical Earnings
PALI Historical Earnings
PASG Historical Earnings
PAVM Historical Earnings
PBH Historical Earnings
What was the record high OTLK historical earnings result?
In terms of earnings or revenue, what is the best OTLK historical earnings result that Outlook Therapeutics has ever posted, and when?

✔️Accepted answer: Within our data set, the highest OTLK historical earnings result was set in Q4 2019, when Outlook Therapeutics posted results of 1.000/share. The most successful revenue quarter within our data set was Q4 2019 when Outlook Therapeutics reported revenue of 5.85M.

What was the lowest Outlook Therapeutics historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest OTLK has reported, and when?

✔️Accepted answer: Within our data set, the lowest OTLK historical earnings result was set in Q1 2020, when Outlook Therapeutics posted results of -12.400/share. The smallest revenue quarter within our data set was Q2 2024 when Outlook Therapeutics reported revenue of NA.

On this page we presented the OTLK historical earnings date information for Outlook Therapeutics. Reviewing that OTLK Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q4 2019, when OTLK posted adjusted EPS of 1.000/share. Meanwhile the lowest OTLK historical earnings result was in Q1 2020, when OTLK posted adjusted EPS of -12.400/share. Moving to Outlook Therapeuticss historical revenue numbers, the largest revenue quarter in our data set was seen in Q4 2019 when OTLK reported 5.85M in revenue, while the smallest revenue quarter was Q2 2024 when OTLK reported NA in revenue.

For self directed investors doing their due diligence on OTLK or any other given stock, their research can benefit from looking into all of the Outlook Therapeutics historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into Outlook Therapeutics historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for OTLK. Thanks for visiting, and the next time you need to research OTLK historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: SLGC market cap history, MS Options Chain, EDG Insider Buying.


OTLK Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
Wait! Don't leave yet.
Want to receive our latest research absolutely free?

Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.